Cargando…
Neuroprotection for Age-Related Macular Degeneration
Age-related macular degeneration (AMD) is a leading cause of blindness worldwide. Early to intermediate AMD is characterized by the accumulation of lipid- and protein-rich drusen. Late stages of the disease are characterized by the development of choroidal neovascularization, termed “exudative” or “...
Autores principales: | Lin, Jonathan B., Murakami, Yusuke, Miller, Joan W., Vavvas, Demetrios G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9767822/ https://www.ncbi.nlm.nih.gov/pubmed/36570623 http://dx.doi.org/10.1016/j.xops.2022.100192 |
Ejemplares similares
-
Advances in Age-related Macular Degeneration Understanding and Therapy
por: Miller, Joan W, et al.
Publicado: (2017) -
A Review of Completed and Ongoing Complement Inhibitor Trials for Geographic Atrophy Secondary to Age-Related Macular Degeneration
por: Halawa, Omar A., et al.
Publicado: (2021) -
Systemic Complement Activation Profiles in Nonexudative Age-Related Macular Degeneration: A Systematic Review
por: Lin, Jonathan B., et al.
Publicado: (2022) -
Systemic Complement Activation Profiles in Nonexudative Age-Related Macular Degeneration: A Meta-Analysis
por: Lin, Jonathan B., et al.
Publicado: (2022) -
Systemic Dyslipidemia in Age-related Macular Degeneration: An Updated Systematic Review and Meta-analysis
por: Li, Brandon, et al.
Publicado: (2023)